New Oral Anticoagulants for Atrial Fibrillation: A Review of Clinical Trials
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference22 articles.
1. Heart disease and stroke statistics—2010 update: a report from the American Heart Association;Lloyd-Jones;Circulation,2010
2. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition);Singer;Chest,2008
3. Essential warfarin knowledge;Neel,2007
4. Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa;Bauer;J Thromb Haemost,2011
5. Pharmacology and therapeutics: the potential role of new anticoagulants in the prevention and treatment of thromboembolism;Mavrakanas;Pharmacol Ther,2011
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Research Progress of Direct Thrombin Inhibitors;Mini-Reviews in Medicinal Chemistry;2020-11-10
2. Comparative Effectiveness and Safety of Rivaroxaban in Adults With Nonvalvular Atrial Fibrillation;American Journal of Therapeutics;2019-11
3. Usefulness of platelet-rich fibrin as a hemostatic agent after dental extractions in patients receiving anticoagulant therapy with factor Xa inhibitors: a case series;Oral and Maxillofacial Surgery;2019-05-17
4. Relationship between warfarin dosage and international normalized ratio: a dose–response analysis and evaluation based on multicenter data;European Journal of Clinical Pharmacology;2019-04-29
5. Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study;Drugs in R&D;2018-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3